Domino liver transplantation in maple syrup urine disease: A case report and review of the literature

I. R. Badell, S. I. Hanish, C. B. Hughes, W. R. Hewitt, R. T. Chung, J. R. Spivey, S. J. Knechtle

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Improved outcomes have expanded the indications for liver transplantation, thus aggravating the already limited supply of donor organs. Domino liver transplantation (DLT) has been one strategy to augment the supply of donor organs in cases of inborn errors of metabolism. One such disease is maple syrup urine disease (MSUD), an inherited disorder of branched-chain amino acid (BCAA) metabolism. Methods: We report on the transplantation of a deceased donor liver into a patient with MSUD, and the sequential transplantation of the explanted liver into a patient with hemophilia A, HIV, hepatitis C, and a low priority on the transplant waiting list. Results: At 30 months, the MSUD recipient has had significant correction of BCAA metabolism on a protein-unrestricted diet and no progression of neuropsychiatric symptoms. The DLT recipient has been cured of hemophilia and has normal BCAA homeostasis. This case provides further evidence that elective orthotopic liver transplantation for MSUD attenuates the disease with restoration of BCAA metabolism, and that DLT in this setting can achieve excellent results in ESLD patients. Conclusion: It is possible that domino grafts from patients with MSUD could be used in more conventional recipients, but additional studies and longer-term outcomes are needed to determine the validity of DLT in MSUD.

Original languageEnglish (US)
Pages (from-to)806-809
Number of pages4
JournalTransplantation Proceedings
Volume45
Issue number2
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Fingerprint

Maple Syrup Urine Disease
Liver Transplantation
Branched Chain Amino Acids
Hemophilia A
Tissue Donors
Transplants
Inborn Errors Metabolism
Waiting Lists
Hepatitis C
Homeostasis
Transplantation
HIV
Diet
Liver

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Domino liver transplantation in maple syrup urine disease : A case report and review of the literature. / Badell, I. R.; Hanish, S. I.; Hughes, C. B.; Hewitt, W. R.; Chung, R. T.; Spivey, J. R.; Knechtle, S. J.

In: Transplantation Proceedings, Vol. 45, No. 2, 01.03.2013, p. 806-809.

Research output: Contribution to journalArticle

Badell, I. R. ; Hanish, S. I. ; Hughes, C. B. ; Hewitt, W. R. ; Chung, R. T. ; Spivey, J. R. ; Knechtle, S. J. / Domino liver transplantation in maple syrup urine disease : A case report and review of the literature. In: Transplantation Proceedings. 2013 ; Vol. 45, No. 2. pp. 806-809.
@article{699d0dcfafad4d048904b5e15575f639,
title = "Domino liver transplantation in maple syrup urine disease: A case report and review of the literature",
abstract = "Background: Improved outcomes have expanded the indications for liver transplantation, thus aggravating the already limited supply of donor organs. Domino liver transplantation (DLT) has been one strategy to augment the supply of donor organs in cases of inborn errors of metabolism. One such disease is maple syrup urine disease (MSUD), an inherited disorder of branched-chain amino acid (BCAA) metabolism. Methods: We report on the transplantation of a deceased donor liver into a patient with MSUD, and the sequential transplantation of the explanted liver into a patient with hemophilia A, HIV, hepatitis C, and a low priority on the transplant waiting list. Results: At 30 months, the MSUD recipient has had significant correction of BCAA metabolism on a protein-unrestricted diet and no progression of neuropsychiatric symptoms. The DLT recipient has been cured of hemophilia and has normal BCAA homeostasis. This case provides further evidence that elective orthotopic liver transplantation for MSUD attenuates the disease with restoration of BCAA metabolism, and that DLT in this setting can achieve excellent results in ESLD patients. Conclusion: It is possible that domino grafts from patients with MSUD could be used in more conventional recipients, but additional studies and longer-term outcomes are needed to determine the validity of DLT in MSUD.",
author = "Badell, {I. R.} and Hanish, {S. I.} and Hughes, {C. B.} and Hewitt, {W. R.} and Chung, {R. T.} and Spivey, {J. R.} and Knechtle, {S. J.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.transproceed.2012.04.031",
language = "English (US)",
volume = "45",
pages = "806--809",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Domino liver transplantation in maple syrup urine disease

T2 - A case report and review of the literature

AU - Badell, I. R.

AU - Hanish, S. I.

AU - Hughes, C. B.

AU - Hewitt, W. R.

AU - Chung, R. T.

AU - Spivey, J. R.

AU - Knechtle, S. J.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Background: Improved outcomes have expanded the indications for liver transplantation, thus aggravating the already limited supply of donor organs. Domino liver transplantation (DLT) has been one strategy to augment the supply of donor organs in cases of inborn errors of metabolism. One such disease is maple syrup urine disease (MSUD), an inherited disorder of branched-chain amino acid (BCAA) metabolism. Methods: We report on the transplantation of a deceased donor liver into a patient with MSUD, and the sequential transplantation of the explanted liver into a patient with hemophilia A, HIV, hepatitis C, and a low priority on the transplant waiting list. Results: At 30 months, the MSUD recipient has had significant correction of BCAA metabolism on a protein-unrestricted diet and no progression of neuropsychiatric symptoms. The DLT recipient has been cured of hemophilia and has normal BCAA homeostasis. This case provides further evidence that elective orthotopic liver transplantation for MSUD attenuates the disease with restoration of BCAA metabolism, and that DLT in this setting can achieve excellent results in ESLD patients. Conclusion: It is possible that domino grafts from patients with MSUD could be used in more conventional recipients, but additional studies and longer-term outcomes are needed to determine the validity of DLT in MSUD.

AB - Background: Improved outcomes have expanded the indications for liver transplantation, thus aggravating the already limited supply of donor organs. Domino liver transplantation (DLT) has been one strategy to augment the supply of donor organs in cases of inborn errors of metabolism. One such disease is maple syrup urine disease (MSUD), an inherited disorder of branched-chain amino acid (BCAA) metabolism. Methods: We report on the transplantation of a deceased donor liver into a patient with MSUD, and the sequential transplantation of the explanted liver into a patient with hemophilia A, HIV, hepatitis C, and a low priority on the transplant waiting list. Results: At 30 months, the MSUD recipient has had significant correction of BCAA metabolism on a protein-unrestricted diet and no progression of neuropsychiatric symptoms. The DLT recipient has been cured of hemophilia and has normal BCAA homeostasis. This case provides further evidence that elective orthotopic liver transplantation for MSUD attenuates the disease with restoration of BCAA metabolism, and that DLT in this setting can achieve excellent results in ESLD patients. Conclusion: It is possible that domino grafts from patients with MSUD could be used in more conventional recipients, but additional studies and longer-term outcomes are needed to determine the validity of DLT in MSUD.

UR - http://www.scopus.com/inward/record.url?scp=84875217059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875217059&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2012.04.031

DO - 10.1016/j.transproceed.2012.04.031

M3 - Article

C2 - 23267808

AN - SCOPUS:84875217059

VL - 45

SP - 806

EP - 809

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2

ER -